Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition
Status:
Completed
Trial end date:
2001-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics and bioequivalence of
isotretinoin formulations after administration of single doses to normal, non-smoking,healthy
males under fasting conditions